After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $300.0 and $340.0 for Cigna Group, spanning the last three months ...

Humana faces real challenges like falling Medicare star ratings, shrinking margins, and tough competition. Click here to read ...

A high-level overview of The Cigna Group (CI) stock. View (CI) real-time stock price, chart, news, analysis, analyst reviews and more.

Cigna’s earnings beat Wall Street expectations, providing relief to investors who had soured on the struggles of insurers’ Medicare and Medicaid businesses. The company, parent of a health ...

Cigna Group just sweetened the deal for its shareholders by announcing a hearty increase in its quarterly dividend to $1.51 ...

Cigna, a $90 billion healthcare behemoth, may fly under the radar, but don't let its quiet facade fool you. The company boasts a robust $180 billion in annual revenue and a striking 20%+ return on ...

The stock's rise snapped a three-day losing streak.

The 12-month price targets, analyzed by analysts, offer insights with an average target of $53.75, a high estimate of $57.00, ...

Caremark will provide outpatient prescription drug benefits to nearly 587,000 members enrolled in Basic or Medicare HMO and PPO plans, which is roughly 40% of CalPERS’ 1.5 million beneficiaries. CVS ...

Investors soured on the sector when Elevance, an insurer, handed in disappointing results and shared a downbeat outlook.

Elevance Health earns a narrow moat rating from us, which is fundamentally anchored by its competitive advantages in medical insurance. Elevance's strategy centers on emphasizing its strengths in the ...